OpenEvidence is a United States-based AI startup that aims to organize the world’s medical knowledge and make it more useful. Launched during the Mayo Clinic Platform Accelerate program, the company has been featured by the New England Journal of Medicine AI and powers Elsevier’s ClinicalKey AI across a multitude of respected journals including Lancet, Cell, and Gray's Anatomy. Founded in 2021, OpenEvidence received a substantial $27.00M Series B investment on 01 July 2022, with notable investors including Ken Moelis, Jim Breyer, and Brian Sheth. This recent investment is expected to further propel the company's leading position in the medical AI sphere.
